World AIDS Day: Combined prevention is the best way to combat HIV and other STIs

Press Contacts

Santé publique France
presse@santepubliquefrance.fr

Stéphanie Champion: 01 41 79 67 48
Marie Delibéros: 01 41 79 69 61
Camille Le Hyaric: 01 41 79 68 64

To mark World AIDS Day, Santé publique France is releasing the updated 2022 surveillance indicators for HIV and bacterial sexually transmitted infections (STIs) in France.

These figures show an increase in the number of tests performed that exceeds the level reached in 2019, before the COVID-19 pandemic. While the number of HIV diagnoses has declined compared to 2019, it continues to rise for other STIs. Condoms, PrEP, TPE, TasP, vaccines, testing: there are now many prevention tools available to combat these infections. To encourage the use of this combination of prevention methods, Santé publique France, in partnership with the Ministry of Health and Prevention, has been rolling out the second phase of its campaign “Everyone has questions about sexuality” since November 24.

HIV and STI testing rates are rising and exceed pre-COVID-19 levels

Screening activity is increasing in 2022 for all STIs.

The number of tests for the three bacterial STIs continued to rise in 2022, a trend observed for several years, with the exception of a one-time drop in 2020. In 2022, 2.6 million people received at least one reimbursed test for Chlamydia trachomatis infection, 3.0 million for gonococcal infection, and 3.1 million for syphilis. HIV testing activity exceeded 2019 levels, with 6.5 million HIV serology tests performed by clinical laboratories.

Continued rise in diagnoses of bacterial STIs

The number of diagnoses of Chlamydia trachomatis, gonorrhea, and syphilis has increased in recent years. Chlamydia trachomatis infection is now diagnosed more frequently in men than in women. Cases of gonorrhea and syphilis are predominantly diagnosed in men, with men who have sex with men (MSM) accounting for the majority of cases.

A mixed picture regarding new HIV diagnoses

The number of people who learned of their HIV-positive status in 2022 was estimated at between 4,200 and 5,700, figures lower than those in 2019; given the increase in testing volume, this is encouraging in terms of the epidemic’s trajectory.

The trend varies by population group. The number of new HIV diagnoses continues to decline among MSM born in France, who accounted for 27% of new diagnoses in 2022. The decline observed since 2016 is likely due to the growing adoption of PrEP in this population. Conversely, the number of new HIV diagnoses continues to rise among MSM born abroad.

More than half of the new HIV diagnoses in 2022 (56%) were among people born abroad, whether they were infected through heterosexual intercourse or sex between men, highlighting the importance of ensuring this population has access to care and of intensifying prevention efforts targeting them.

"On this World AIDS Day, it is important to remember that the earlier sexually transmitted infections are detected, the earlier the diagnosis and the more appropriate the treatment. This also helps limit the spread of these infections. Screening rates are on the rise again, but we must continue to work together as a community. There are many ways to protect yourself and others, including PrEP, which is still underutilized by eligible individuals. Combined prevention must be widely known and accessible to all. This is the goal of the campaign we are currently promoting. In terms of surveillance, the involvement of clinicians and laboratory professionals is essential for mandatory HIV reporting (DO) to monitor the national sexual health strategy. The fight against HIV and other STIs is a public health issue; everyone can take action to stop the transmission of these infections."

Dr. Caroline Semaille, Director General of Santé publique France

Download

bulletin national

28 November 2023

HIV/STI Public Health Bulletin. November 2023.

An awareness campaign on the importance of combined STI and HIV prevention

Once again this year, indicators highlight the importance of being well-informed about the variety and complementary nature of tools for protecting against and screening for STIs and HIV (condoms, PrEP, TPE, TasP, STI vaccination, screening). That is why, on World AIDS Day, Santé publique France is launching the second phase of the “Everyone has questions about sexuality” campaign, dedicated to STIs and HIV.

wide

The campaign aims to encourage the use of combination prevention and testing by improving awareness of these prevention tools, some of which are still little known. It targets the general public as well as key populations in the fight against HIV—people from sub-Saharan Africa (a region with high prevalence) and men who have sex with men—as well as healthcare professionals who prescribe these prevention methods.

Available on TV, digital platforms, and billboards, it addresses the most common questions about protection against STIs and promotes the availability of certain free prevention tools.

broad

Thanks in particular to a dedicated TV spot, the campaign highlights PrEP, a tool that has been available to the MSM population since 2016 but is still underutilized among migrant populations and requires quarterly STI testing. An advertorial in the trade press, produced in collaboration with the association Vers Paris sans Sida, highlights the importance of promoting this tool among the migrant population, particularly women, who currently account for only 3% of PrEP users1.

The campaign also has two specific components dedicated to migrant populations from sub-Saharan Africa and to MSM. For migrant populations, the initiative is being rolled out through a network of retail outlets and on social media, and will be featured in a radio program; for MSM, it is being rolled out online and through a network of affinity-based posters, as well as via community media.

To support healthcare professionals and other field workers in their practice, Santé publique France provides various tools (brochures, posters, photo stories, etc.), which are available for download and can be ordered.

QuestionSexualite.fr: The Go-To Website

Aimed at the entire adult population, QuestionSexualite.fr is the go-to website for sexual health. Taking a comprehensive and positive approach to prevention, the site addresses various topics, such as HIV and STI prevention, through simple, detailed content validated by experts. Interactive tools are also available on the site, including an interactive map to help users find the nearest testing center or sexual health clinic.

The QuestionSexualite.fr website complements Santé publique France’s digital ecosystem for sexual health (OnSEXprime.fr for adolescents and Sexosafe.fr for men who have sex with men).

1-Epi-phare. Monitoring the use of pre-exposure prophylaxis (PrEP) for HIV. 2022

thematic dossier

Sexually transmitted infections

Les infections sexuellement transmissibles (IST) se transmettent principalement lors des rapports sexuels. Il existe de nombreux virus ou bactéries transmissibles de cette manière.

Sexual health

thematic dossier

Santé publique France focuses in particular on four areas of sexual health: sexually transmitted infections, including HIV; contraception; combating discrimination; and violence.

Sexuality

A website that provides answers to questions about sexuality, anatomy, sexual practices, pregnancy, STIs, and discrimination based on sexual orientation.

Safe Sex

HIV and STI prevention, testing, and sexual orientation—the Sexosafe website addresses issues related to sexuality among men.

Let's express ourselves

First experiences, puberty, romantic relationships, and safe sex—the Onsexprime website is dedicated to young people’s sexuality and everything related to it, offering educational...

Our latest news

news

2026 “Sexual Behavior” Survey (ERAS) for men who have sex with men

news

Hervé Maisonneuve has been appointed scientific integrity officer for a...

Visuel illustratif

news

Public Health France 2026 Barometer: Launch of the Survey